» Articles » PMID: 35361933

Reprogramming of Fibroblasts into Expandable Cardiovascular Progenitor Cells Via Small Molecules in Xeno-free Conditions

Overview
Journal Nat Biomed Eng
Publisher Springer Nature
Date 2022 Apr 1
PMID 35361933
Authors
Affiliations
Soon will be listed here.
Abstract

A major hurdle in cardiac cell therapy is the lack of a bona fide autologous stem-cell type that can be expanded long-term and has authentic cardiovascular differentiation potential. Here we report that a proliferative cell population with robust cardiovascular differentiation potential can be generated from mouse or human fibroblasts via a combination of six small molecules. These chemically induced cardiovascular progenitor cells (ciCPCs) self-renew long-term in fully chemically defined and xeno-free conditions, with faithful preservation of the CPC phenotype and of cardiovascular differentiation capacity in vitro and in vivo. Transplantation of ciCPCs into infarcted mouse hearts improved animal survival and cardiac function up to 13 weeks post-infarction. Mechanistically, activated fibroblasts revert to a plastic state permissive to cardiogenic signals, enabling their reprogramming into ciCPCs. Expanded autologous cardiovascular cells may find uses in drug discovery, disease modelling and cardiac cell therapy.

Citing Articles

regulates cervical cancer by proliferative cells: mendelian randomization and single-cell transcriptomics analyses.

Wang Y, Yao J, Wei M, Jiang Q, Luo H, Lai S Transl Cancer Res. 2025; 14(1):354-370.

PMID: 39974380 PMC: 11833381. DOI: 10.21037/tcr-24-949.


Chemical evocation of human cell plasticity-twist of cell fates by small molecules.

Liu G, Fu J, Cao N Life Med. 2025; 1(2):71-73.

PMID: 39871922 PMC: 11749130. DOI: 10.1093/lifemedi/lnac010.


Enhancing Cardiomyocyte Purity through Lactate-Based Metabolic Selection.

Seo S, Jin Y Tissue Eng Regen Med. 2025; 22(2):249-260.

PMID: 39820961 PMC: 11794935. DOI: 10.1007/s13770-024-00696-4.


Chemically defined and growth factor-free system for highly efficient endoderm induction of human pluripotent stem cells.

Zhao Z, Zeng F, Nie Y, Lu G, Xu H, En H Stem Cell Reports. 2024; 20(1):102382.

PMID: 39729989 PMC: 11784501. DOI: 10.1016/j.stemcr.2024.11.012.


Partial Cell Fate Transitions to Promote Cardiac Regeneration.

Yang J Cells. 2024; 13(23).

PMID: 39682750 PMC: 11640292. DOI: 10.3390/cells13232002.


References
1.
Laugwitz K, Moretti A, Lam J, Gruber P, Chen Y, Woodard S . Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature. 2005; 433(7026):647-53. PMC: 5578466. DOI: 10.1038/nature03215. View

2.
van Berlo J, Kanisicak O, Maillet M, Vagnozzi R, Karch J, Lin S . c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature. 2014; 509(7500):337-41. PMC: 4127035. DOI: 10.1038/nature13309. View

3.
Vagnozzi R, Sargent M, Lin S, Palpant N, Murry C, Molkentin J . Genetic Lineage Tracing of Sca-1 Cells Reveals Endothelial but Not Myogenic Contribution to the Murine Heart. Circulation. 2018; 138(25):2931-2939. PMC: 6843990. DOI: 10.1161/CIRCULATIONAHA.118.035210. View

4.
Neidig L, Weinberger F, Palpant N, Mignone J, Martinson A, Sorensen D . Evidence for Minimal Cardiogenic Potential of Stem Cell Antigen 1-Positive Cells in the Adult Mouse Heart. Circulation. 2018; 138(25):2960-2962. PMC: 6296850. DOI: 10.1161/CIRCULATIONAHA.118.035273. View

5.
Chien K, Frisen J, Fritsche-Danielson R, Melton D, Murry C, Weissman I . Regenerating the field of cardiovascular cell therapy. Nat Biotechnol. 2019; 37(3):232-237. DOI: 10.1038/s41587-019-0042-1. View